Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03396471
Title Study of Pembrolizumab and Concurrent Radiation in Patients With Previously Treated Carcinoma of Unknown Primary
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Hoosier Cancer Research Network
Indications

carcinoma

squamous cell carcinoma

adenocarcinoma

Therapies

Pembrolizumab

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.